HealthEquity (HQY) to Release Earnings on Tuesday

HealthEquity (NASDAQ:HQY) is expected to release its Q4 2026 results after the market closes on Tuesday, March 17th. Analysts expect HealthEquity to post earnings of $0.89 per share and revenue of $332.4790 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2026 earning overview page for the latest details on the call scheduled for Tuesday, March 17, 2026 at 4:30 PM ET.

HealthEquity Stock Up 2.1%

Shares of HQY opened at $80.04 on Tuesday. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity has a 12 month low of $72.76 and a 12 month high of $116.65. The stock’s 50 day moving average is $83.02 and its two-hundred day moving average is $90.71. The firm has a market cap of $6.84 billion, a P/E ratio of 36.72, a PEG ratio of 0.98 and a beta of 0.26.

Analysts Set New Price Targets

HQY has been the topic of a number of recent analyst reports. The Goldman Sachs Group lowered HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a research report on Friday, January 9th. Jefferies Financial Group set a $108.00 price target on shares of HealthEquity in a report on Thursday, February 19th. Raymond James Financial set a $100.00 price objective on shares of HealthEquity in a research report on Tuesday, February 17th. Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. Finally, BMO Capital Markets set a $85.00 target price on shares of HealthEquity in a research note on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $112.00.

Insider Activity at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of HQY. Corient Private Wealth LLC acquired a new position in HealthEquity during the fourth quarter worth about $219,000. Pacer Advisors Inc. raised its holdings in HealthEquity by 16.9% in the 4th quarter. Pacer Advisors Inc. now owns 13,427 shares of the company’s stock valued at $1,230,000 after acquiring an additional 1,937 shares during the last quarter. Virtu Financial LLC purchased a new position in HealthEquity in the 4th quarter worth approximately $325,000. EP Wealth Advisors LLC purchased a new position in HealthEquity in the 4th quarter worth approximately $472,000. Finally, XTX Topco Ltd acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $289,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.